These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33741793)

  • 1. Antimicrobial use in central nervous system infections.
    Ciummo F; Srinivas P; Biedny J
    Curr Opin Infect Dis; 2021 Jun; 34(3):255-263. PubMed ID: 33741793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal or intraventricular colistin: a review.
    Bargiacchi O; De Rosa FG
    Infez Med; 2016; 24(1):3-11. PubMed ID: 27031890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.
    LeBras M; Chow I; Mabasa VH; Ensom MH
    Neurocrit Care; 2016 Dec; 25(3):492-507. PubMed ID: 27043949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system infections associated with neurologic devices.
    Bloch K; Hasbun R
    Curr Opin Infect Dis; 2021 Jun; 34(3):238-244. PubMed ID: 33741795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state.
    Remeš F; Tomáš R; Jindrák V; Vaniš V; Setlík M
    J Neurosurg; 2013 Dec; 119(6):1596-602. PubMed ID: 23952688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series.
    Tsolaki V; Karvouniaris M; Manoulakas E; Kotlia P; Karadontas V; Fotakopoulos G; Zakynthinos E; Makris D
    J Crit Care; 2018 Oct; 47():338-341. PubMed ID: 30097260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study.
    Lewin JJ; Cook AM; Gonzales C; Merola D; Neyens R; Peppard WJ; Brophy GM; Kurczewski L; Giarratano M; Makii J; Rowe AS; Tesoro EP; Zaniewski A; Clark S; Ziai WC
    Neurocrit Care; 2019 Jun; 30(3):609-616. PubMed ID: 30446934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria.
    Imberti R; Iotti GA; Regazzi M
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):471-8. PubMed ID: 24597575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial bacterial meningitis, including central nervous system shunt infections.
    Morris A; Low DE
    Infect Dis Clin North Am; 1999 Sep; 13(3):735-50. PubMed ID: 10470564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare-associated central nervous system infections.
    Ippolito M; Giarratano A; Cortegiani A
    Curr Opin Anaesthesiol; 2022 Oct; 35(5):549-554. PubMed ID: 35943123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogen Analysis of Central Nervous System Infections in a Chinese Teaching Hospital from 2012-2018: A Laboratory-based Retrospective Study.
    Tian L; Zhang Z; Sun ZY
    Curr Med Sci; 2019 Jun; 39(3):449-454. PubMed ID: 31209818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections of cerebrospinal fluid diversion devices in adults: the role of intraventricular antimicrobial therapy.
    Wilkie MD; Hanson MF; Statham PF; Brennan PM
    J Infect; 2013 Mar; 66(3):239-46. PubMed ID: 23195031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chryseobacterium indologenes central nervous system infection in infancy: an emergent pathogen?
    Olbrich P; Rivero-Garvía M; Falcón-Neyra MD; Lepe JA; Cisneros JM; Marquez-Rivas J; Neth O
    Infection; 2014 Feb; 42(1):179-83. PubMed ID: 23709293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
    Khawcharoenporn T; Apisarnthanarak A; Mundy LM
    Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.
    Nevrekar S; Cunningham KC; Greathouse KM; Panos NG
    Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive intraventricular antibiotic therapy for bacterial central nervous system infections in critically ill patients with traumatic brain injury.
    McClellan N; Swanson JM; Magnotti LJ; Griffith TW; Wood GC; Croce MA; Boucher BA; Mueller EW; Fabian TC
    Ann Pharmacother; 2015 May; 49(5):515-22. PubMed ID: 25690904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections.
    Nau R; Seele J; Eiffert H
    Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.